特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
921936

世界の癒着防止材市場:成長、動向、および予測

Adhesion Barrier Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
世界の癒着防止材市場:成長、動向、および予測
出版日: 2020年06月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 111 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートは世界の癒着防止材市場について調査しており、市場機会や動向、成長および阻害要因、製品・形態・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
    • 手術・スポーツ関連の負傷件数の増加
    • 癒着の医学的意義についての意識の高まり
  • 市場阻害要因
    • 外科医の間の癒着障壁の使用に対する不本意
    • 限られた技術革新をもたらす厳しい規制
  • ポーターのファイブフォース分析

第5章 市場セグメンテーション

  • 製品別
    • 合成接着バリア
    • 自然接着バリア
  • 形態別
    • フィルム
    • 液体
    • ゲル
  • 用途別
    • 一般/腹部手術
    • 婦人科手術
    • 心臓血管手術
    • 整形外科
    • 神経外科
    • 再建手術
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Anika Therapeutics
    • Baxter International
    • Becton Dickinson and Company
    • Betatech Medical
    • FzioMed
    • Innocoll Holdings
    • Integra LifeSciences Holdings Corporation
    • Johnson & Johnson
    • MAST Biosurgery
    • Sanofi

第7章 市場機会および今後の動向

目次
Product Code: 67614

Certain factors that are driving the market growth include increase in the volume of surgeries and sports-related injuries and rising awareness about the medical implications of adhesions.

Trauma during surgery can result in fibrous bands connecting surfaces which are normally separate. Adhesions occur despite the best surgical techniques, and such formation of adhesions after surgery causes high morbidity. An effective adhesion barrier for surgery helps reduce the incidence, extent, and severity of postoperative adhesions. Barriers to prevent adhesion should therefore be applied, owing to their ability to reduce the severity of adhesion formation. The oxidised regenerated cellulose and hyaluronate carboxymethylcellulose can safely reduce clinically relevant consequences of adhesions. Hence, due to such benefits associated with the adhesion barriers, the market is expected to observe a steady growth over the forecast period.

Key Market Trends

General/Abdominal Surgery is Expected to Hold Significant Market Share in the Application Segment

Adhesive disease represents a significant cause of morbidity for postoperative patients. Most surgical procedures performed by obstetrician and gynecologists are associated with pelvic adhesions that cause subsequent serious sequelae, including small bowel obstruction, infertility, chronic pelvic pain, and difficulty in postoperative treatment, including complexity during subsequent surgical procedures. Adhesion barriers have proven to reduce adhesion-related complications in abdominal surgery. The use of adhesion barriers in open surgery is cost-effective in preventing adhesion-related problems.

Furthermore, companies expansions and new developments in abdominal barriers expected to boost market growth. For instance, in February 2020, Baxter completed the acquisition of Seprafilm Adhesion Barrier and its assets from Sanofi in a deal worth USD 350 million. Seprafilm is used as an adjunct to reduce the incidence, extent and severity of adhesions in pelvic and abdominal surgeries. Thus the market for general/abdominal Surgery expected to have notable growth rate over the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

The increasing rate of surgery in the region has been well-documented. The growth in the United States is driven by technological advancement, elderly patients expecting higher levels of function, and reimbursement models that incentivize complex fusion surgery. Adhesion barriers are also useful in oncology surgeries. As per the American Cancer Society's estimation, the new cases of lung cancer in the United States for 2018 are likely to be around 234,030, and about 154,050 deaths are expected due to lung cancer. The National Institutes of Health estimated that cancer care costs the United States an overall USD 147.5 billion in 2015, USD 13.4 billion of which is due to lung cancer. Surgeons believe that they can cost-effectively reduce the risk of post-operative complications in patients by using the adhesion barriers and hence, these new advances are expected to propel the growth of the market in North America.

Competitive Landscape

The global Adhesion Barrier market is moderately competitive and consists of a few major players. Companies like Anika Therapeutics, Baxter International, Becton, Dickinson and Company, Betatech Medical, FzioMed, Innocoll Holdings, Integra LifeSciences Holdings Corporation, Johnson & Johnson, MAST Biosurgery, Sanofi, among others, hold the substantial market share in the Adhesion Barrier market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in the Volume of Surgeries and Sports-Related Injuries
    • 4.2.2 Rising Awareness About the Medical Implications of Adhesions
  • 4.3 Market Restraints
    • 4.3.1 Reluctance Towards the Usage of Adhesion Barriers Among Surgeons
    • 4.3.2 Stringent Regulations Resulting in Limited Technological Innovations
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Synthetic Adhesion Barriers
      • 5.1.1.1 Hyaluronic Acid
      • 5.1.1.2 Regenerated Cellulose
      • 5.1.1.3 Polyethylene Glycol
      • 5.1.1.4 Others
    • 5.1.2 Natural Adhesion Barriers
      • 5.1.2.1 Collagen & Protein
      • 5.1.2.2 Fibrin
  • 5.2 By Formulation
    • 5.2.1 Film
    • 5.2.2 Liquid
    • 5.2.3 Gel
  • 5.3 By Application
    • 5.3.1 General/Abdominal Surgeries
    • 5.3.2 Gynecological Surgeries
    • 5.3.3 Cardiovascular Surgeries
    • 5.3.4 Orthopedic Surgeries
    • 5.3.5 Neurological Surgeries
    • 5.3.6 Reconstructive Surgeries
    • 5.3.7 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Anika Therapeutics
    • 6.1.2 Baxter International
    • 6.1.3 Becton Dickinson and Company
    • 6.1.4 Betatech Medical
    • 6.1.5 FzioMed
    • 6.1.6 Innocoll Holdings
    • 6.1.7 Integra LifeSciences Holdings Corporation
    • 6.1.8 Johnson & Johnson
    • 6.1.9 MAST Biosurgery

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.